{"id":"W2278581713","doi":"10.1200/jco.2013.31.15_suppl.tps664","title":"Human epidermal growth factor receptor 2 (HER2) suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (HALT: LPT112515).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Lapatinib; Medicine; Trastuzumab; Tolerability; Discontinuation; Internal medicine; Metastatic breast cancer; Clinical endpoint; Oncology; Breast cancer; Chemotherapy; Cancer; Adverse effect; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008198052,0.0008063306,0.001077127,0.000399739,0.0002491767,0.0005765634,0.0007198365,0.0007570068,0.002989946],"category_scores_gemma":[0.0004640148,0.0003397593,0.0007581504,0.0003446222,0.0007428512,0.0006769497,0.0003851374,0.002298227,0.0005728479],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005672178,"about_ca_system_score_gemma":0.0008882885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005097431,"about_ca_topic_score_gemma":0.001442237,"domain_scores_codex":[0.9997612,0.00008925634,0.00001762747,0.00004104095,0.00003007202,0.00006092457],"domain_scores_gemma":[0.9997467,0.00004268983,0.00006657132,0.00002211553,0.000008736763,0.0001131725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4947093,0.08369222,0.01344272,0.001596401,0.001034089,0.0008062816,0.0003282368,0.003209866,0.1503459,0.000589036,0.006632068,0.2436139],"study_design_scores_gemma":[0.2417015,0.7041474,0.01850282,0.00005432284,0.0004980793,0.001206931,0.00007157723,0.001498282,0.02715947,0.0002110459,0.004909041,0.00003946154],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962959,0.001199038,0.0001838491,0.0002227309,0.00006954223,0.0005038106,0.0003816989,0.00007583973,0.001067539],"genre_scores_gemma":[0.9952916,0.00102565,0.0005561586,0.0002513854,0.00007289837,0.0006157195,0.0009636061,0.00001042901,0.001212612],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002989946,"threshold_uncertainty_score":0.01000237,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07742957421473282,"score_gpt":0.4619826666063785,"score_spread":0.3845530923916457,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}